Insider · CIK 0001977620
Giles Richard Platford
Files at TAK (TAKEDA PHARMACEUTICAL CO LTD). First filing Aug 12, 2026, latest Aug 12, 2026.
In brief
Giles Richard Platford files SEC Form 4 as president at TAK (TAKEDA PHARMACEUTICAL CO LTD). Since Aug 12, 2026, Giles Richard Platford has reported 0 open-market buys worth $0 and 1 open-market sell worth $532k, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Giles Richard Platford has 0, so none is measured yet.
The newest scored trade: sold $532k of TAK on Aug 10, 2026, filed Aug 12, 2026, scored 53 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $532k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TAK: TAKEDA PHARMACEUTICAL CO LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | TAKEDA PHARMACEUTICAL CO LTD | $532k 31,083 shares | -9% | +33% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 13, 2026 | TAK Takeda Pharmaceutical Company Limited | 33,696 0.02% of outstanding | $564k | Jul 13, 2026 | none |
| Dec 4, 2025 | TAK Takeda Pharmaceutical Company Limited | 58,421 0.05% of outstanding | $836k | Dec 4, 2025 | none |
| Jul 9, 2025 | TAK Takeda Pharmaceutical Company Limited | 28,552 0.02% of outstanding | $440k | Jul 9, 2025 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | SOpen-market sale American Depositary Shares | -31,083 | $17.10 | $532k | 315,838 | Aug 12, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award American Depositary Shares | +49,558 | $0.00 | $0 | 346,921 | Jul 6, 2026 |
| Apr 27, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award American Depositary Shares | +72,124 | $0.00 | $0 | 297,363 | Apr 28, 2026 |
Questions about Giles Richard Platford
Answered from the filings on this page, as of the latest one.
Is Giles Richard Platford buying or selling?
In the last 12 months Giles Richard Platford reported 0 open-market buys worth $0 and 1 open-market sell worth $532k on SEC Form 4; the latest was sold $532k of TAK on Aug 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Giles Richard Platford's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Giles Richard Platford has 0.
Where does Giles Richard Platford file Form 4?
Giles Richard Platford has filed Form 4 at TAK (TAKEDA PHARMACEUTICAL CO LTD) as President, IBU. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.